Trials / Completed
CompletedNCT02380066
Comparison of Anyu Peibo With Placebo in Treatment of MDD
Proof Of Concept Study of Anyu Peibo in the Treatment of Major Depressive Disorder(MDD): a Randomized, Double-Blind, Placebo-Paralleled,Dose-Finding, Multicenter Clinical Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Shanghai Mental Health Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Anyu Peibo Capsule in different doses are effective in the treatment of Depression. And to explore the preliminary information of safety and efficacy of Anyu Peibo Capsule in the Chinese Patients with Depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anyu Peibo | Placebo |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-03-01
- Completion
- 2017-01-01
- First posted
- 2015-03-05
- Last updated
- 2020-01-02
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02380066. Inclusion in this directory is not an endorsement.